Recruiting
Idiopathic pulmonary fibrosis
RecruitingA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
Investigational
A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
Investigational
- Disease:Idiopathic pulmonary fibrosis
- Substances:ABBV-142
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:ABBV-142



